University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Postprandial glycaemic and lipaemic responses to chronic coffee consumption may be modulated by CYP1A2 polymorphisms.

Robertson, Tracey, Clifford, Michael, Penson, S, Williams, Peter and Robertson, Margaret (2018) Postprandial glycaemic and lipaemic responses to chronic coffee consumption may be modulated by CYP1A2 polymorphisms. British Journal of Nutrition, 119 (7). pp. 792-800.

[img]
Preview
Text
BJN Robertson et al 2018.pdf - Accepted version Manuscript

Download (816kB) | Preview

Abstract

There is much epidemiological evidence suggesting a reduced risk of development of type 2 diabetes (T2D) in habitual coffee drinkers, however to date there have been few longer term interventions, directly examining the effects of coffee intake on glucose and lipid metabolism. Previous studies may be confounded by inter-individual variation in caffeine metabolism. Specifically, the rs762551 single nucleotide polymorphism (SNP) in the CYP1A2 gene has been demonstrated to influence caffeine metabolism, with carriers of the C allele considered to be of a “slow” metaboliser phenotype. This study investigated the effects of regular coffee intake on markers of glucose and lipid metabolism in coffee-naïve individuals, with novel analysis by rs762551 genotype. Participants were randomised to either a coffee group (n=19) who consumed 4 cups/day instant coffee for 12 weeks or a control group (n=8) who remained coffee/caffeine free. Venous blood samples were taken pre- and post13 intervention. Primary analysis revealed no significant differences between groups. Analysis of the coffee group by genotype revealed several differences. Prior to coffee intake, the AC genotype (“slow” caffeine metabolisers, n=9) displayed higher baseline glucose and non esterified fatty acids (NEFA) than the AA genotype (“fast” caffeine metabolisers, n=10, p<0.05). Post-intervention, reduced postprandial glycaemia and reduced NEFA suppression were observed in the AC genotype, with the opposite result observed in the AA genotype (p<0.05). These observed differences between genotypes warrant further investigation and indicate there may be no one-size-fits-all recommendation with regard to coffee drinking and T2D risk.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Biosciences and Medicine
Authors :
NameEmailORCID
Robertson, Traceyt.m.robertson@surrey.ac.uk
Clifford, MichaelM.Clifford@surrey.ac.uk
Penson, S
Williams, PeterP.Williams@surrey.ac.uk
Robertson, MargaretM.Robertson@surrey.ac.uk
Date : 23 March 2018
Identification Number : 10.1017/S0007114518000260
Copyright Disclaimer : Copyright 2018 Cambridge University Press. This article has been accepted for publication and will appear in a revised form, subsequent to peer review and/or editorial input by Cambridge University Press, in British Journal of Nutrition, published by Cambridge University Press.
Uncontrolled Keywords : Coffee, caffeine, human, glucose, lipid, metabolism, rs762551, CYP1A2
Depositing User : Melanie Hughes
Date Deposited : 24 Jan 2018 09:57
Last Modified : 23 Mar 2018 13:46
URI: http://epubs.surrey.ac.uk/id/eprint/845673

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800